Linda Griffith

No ORCID on file · 6 papers in corpus · active 2014-2025

Study types

  • article 4
  • other 2

Condition tags

  • endometriosis 6
  • infertility 1
  • endometrioma 1
other 2025
bioRxiv : the preprint server for biology ·doi:10.1101/2025.10.06.680733

The ascent of novel alternative methods (NAMs) in drug development spotlights the dual needs for improved biological fidelity to in vivo along with reproducibility, especially in regulatory applications. The need for pre-clinical models of …

article 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.11.024
article 2019
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2019.12.005
other 2017
Biomaterials ·doi:10.1016/j.biomaterials.2017.03.030

Methods to parse paracrine epithelial-stromal communication networks are a vital need in drug development, as disruption of these networks underlies diseases ranging from cancer to endometriosis. Here, we describe a modular, synthetic, and …

article 2014
Fertility and sterility ·doi:10.1016/j.fertnstert.2014.04.001
article 2014
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2014-1340

BACKGROUND: In endometriosis, the establishment and subsistence of ectopic lesions outside the endometrium suggest an altered cellular state for pathological hyperplasia. Sphingolipids are bioactive compounds, and their biosynthesis and met…